163 related articles for article (PubMed ID: 38613909)
1. Post-operative C-reactive protein as a strong independent predictor of long-term colorectal cancer outcomes: consistent findings from two large patient cohorts.
Gwenzi T; Schrotz-King P; Anker SC; Schöttker B; Hoffmeister M; Brenner H
ESMO Open; 2024 Apr; 9(4):102982. PubMed ID: 38613909
[TBL] [Abstract][Full Text] [Related]
2. Association between post-treatment circulating biomarkers of inflammation and survival among stage II-III colorectal cancer patients.
Hua X; Kratz M; Malen RC; Dai JY; Lindström S; Zheng Y; Newcomb PA
Br J Cancer; 2021 Sep; 125(6):806-815. PubMed ID: 34230610
[TBL] [Abstract][Full Text] [Related]
3. Low plasma vitamin D is associated with adverse colorectal cancer survival after surgical resection, independent of systemic inflammatory response.
Vaughan-Shaw PG; Zgaga L; Ooi LY; Theodoratou E; Timofeeva M; Svinti V; Walker M; O'Sullivan F; Ewing A; Johnston S; Din FVN; Campbell H; Farrington SM; Dunlop MG
Gut; 2020 Jan; 69(1):103-111. PubMed ID: 31023832
[TBL] [Abstract][Full Text] [Related]
4. Blood markers of oxidative stress are strongly associated with poorer prognosis in colorectal cancer patients.
Boakye D; Jansen L; Schöttker B; Jansen EHJM; Schneider M; Halama N; Gào X; Chang-Claude J; Hoffmeister M; Brenner H
Int J Cancer; 2020 Nov; 147(9):2373-2386. PubMed ID: 32319674
[TBL] [Abstract][Full Text] [Related]
5. The impact of postoperative inflammation on recurrence in patients with colorectal cancer.
Matsubara D; Arita T; Nakanishi M; Kuriu Y; Murayama Y; Kudou M; Konishi H; Komatsu S; Shiozaki A; Otsuji E
Int J Clin Oncol; 2020 Apr; 25(4):602-613. PubMed ID: 31758273
[TBL] [Abstract][Full Text] [Related]
6. The Prognostic Value of Post-operative Serum C-reactive Protein Level for -Survival after Surgery for Colorectal Liver Metastases.
van der Stok EP; Grünhagen DJ; Rothbarth J; Verhoef C
Acta Chir Belg; 2015; 115(5):348-55. PubMed ID: 26560001
[TBL] [Abstract][Full Text] [Related]
7. Lymphocyte-C-reactive Protein Ratio as Promising New Marker for Predicting Surgical and Oncological Outcomes in Colorectal Cancer.
Okugawa Y; Toiyama Y; Yamamoto A; Shigemori T; Ide S; Kitajima T; Fujikawa H; Yasuda H; Hiro J; Yoshiyama S; Yokoe T; Saigusa S; Tanaka K; Shirai Y; Kobayashi M; Ohi M; Araki T; McMillan DC; Miki C; Goel A; Kusunoki M
Ann Surg; 2020 Aug; 272(2):342-351. PubMed ID: 32675548
[TBL] [Abstract][Full Text] [Related]
8. Prognostic Value of Post-Operative C-Reactive Protein-Based Inflammatory Biomarkers in Colorectal Cancer Patients: Systematic Review and Meta-Analysis.
Gwenzi T; Zhu A; Schrotz-King P; Schöttker B; Hoffmeister M; Edelmann D; Brenner H
Clin Epidemiol; 2023; 15():795-809. PubMed ID: 37396024
[TBL] [Abstract][Full Text] [Related]
9. Association between preoperative C-reactive protein level and colorectal cancer survival: a meta-analysis.
Woo HD; Kim K; Kim J
Cancer Causes Control; 2015 Nov; 26(11):1661-70. PubMed ID: 26376895
[TBL] [Abstract][Full Text] [Related]
10. Baseline serum C-reactive protein and death from colorectal cancer in the NHANES III cohort.
Swede H; Hajduk AM; Sharma J; Rawal S; Rasool H; Vella AT; Tobet RE; Stevens RG
Int J Cancer; 2014 Apr; 134(8):1862-70. PubMed ID: 24122448
[TBL] [Abstract][Full Text] [Related]
11. Preoperative serum C-reactive protein and its prognostic significance in patients with stage III-IV colorectal cancer.
Lumachi F; Basso SM; Santeufemia DA; Ermani M; Lo Re G; Chiara GB
Anticancer Res; 2014 Dec; 34(12):7263-6. PubMed ID: 25503158
[TBL] [Abstract][Full Text] [Related]
12. Prognostic value of the combination of pre- and postoperative C-reactive protein in colorectal cancer patients.
Yamamoto M; Saito H; Uejima C; Tanio A; Takaya S; Sakamoto T; Honjo S; Maeta Y; Ashida K; Fujiwara Y
Surg Today; 2018 Nov; 48(11):986-993. PubMed ID: 29946884
[TBL] [Abstract][Full Text] [Related]
13. Clinical Significance of the C-Reactive Protein to Albumin Ratio for Survival After Surgery for Colorectal Cancer.
Ishizuka M; Nagata H; Takagi K; Iwasaki Y; Shibuya N; Kubota K
Ann Surg Oncol; 2016 Mar; 23(3):900-7. PubMed ID: 26530445
[TBL] [Abstract][Full Text] [Related]
14. TATI, TAT-2, and CRP as Prognostic Factors in Colorectal Cancer.
Björkman K; Kaprio T; Beilmann-Lehtonen I; Stenman UH; Böckelman C; Haglund C
Oncology; 2022; 100(1):22-30. PubMed ID: 34794144
[TBL] [Abstract][Full Text] [Related]
15. Postoperative C-reactive protein/albumin ratio is a biomarker of risk of recurrence and need for adjuvant chemotherapy for stage III colorectal cancer.
Matsuoka H; Ando K; Hu Q; Zaitsu Y; Tsuda Y; Hisamatsu Y; Nakashima Y; Kimura Y; Oki E; Mori M
Int J Clin Oncol; 2020 Jul; 25(7):1318-1326. PubMed ID: 32279124
[TBL] [Abstract][Full Text] [Related]
16. Colorectal cancer patients with different C-reactive protein levels and 5-year survival times can be differentiated with quantitative serum proteomics.
Holm M; Saraswat M; Joenväärä S; Ristimäki A; Haglund C; Renkonen R
PLoS One; 2018; 13(4):e0195354. PubMed ID: 29630649
[TBL] [Abstract][Full Text] [Related]
17. A case-control study of pre-operative levels of serum neutrophil gelatinase-associated lipocalin and other potential inflammatory markers in colorectal cancer.
Duvillard L; Ortega-Deballon P; Bourredjem A; Scherrer ML; Mantion G; Delhorme JB; Deguelte-Lardière S; Petit JM; Bonithon-Kopp C;
BMC Cancer; 2014 Dec; 14():912. PubMed ID: 25472811
[TBL] [Abstract][Full Text] [Related]
18. Increased serum pentraxin-3 level predicts poor prognosis in patients with colorectal cancer after curative surgery, a cohort study.
Liu B; Zhao Y; Guo L
Medicine (Baltimore); 2018 Oct; 97(40):e11780. PubMed ID: 30290589
[TBL] [Abstract][Full Text] [Related]
19. Clinical significance of preoperative serum vascular endothelial growth factor, interleukin-6, and C-reactive protein level in colorectal cancer.
Kwon KA; Kim SH; Oh SY; Lee S; Han JY; Kim KH; Goh RY; Choi HJ; Park KJ; Roh MS; Kim HJ; Kwon HC; Lee JH
BMC Cancer; 2010 May; 10():203. PubMed ID: 20465852
[TBL] [Abstract][Full Text] [Related]
20. Prognostic role and clinical significance of C-reactive protein-lymphocyte ratio in colorectal cancer.
Meng Y; Long C; Huang X; Huang L; Liao L; Tang W; Liu J
Bioengineered; 2021 Dec; 12(1):5138-5148. PubMed ID: 34436973
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]